Show simple item record

dc.contributor.authorHeeger, C.-H.
dc.contributor.authorPopescu, S.S.
dc.contributor.authorSohns, C.
dc.contributor.authorPott, A.
dc.contributor.authorMetzner, A.
dc.contributor.authorInaba, O.
dc.contributor.authorStraube, F.
dc.contributor.authorKuniss, M.
dc.contributor.authorAryana, A.
dc.contributor.authorMiyazaki, S.
dc.contributor.authorCay, S.
dc.contributor.authorEhrlich, J.R.
dc.contributor.authorEl-Battrawy, I.
dc.contributor.authorMartinek, M.
dc.contributor.authorSaguner, A.M.
dc.contributor.authorTscholl, V.
dc.contributor.authorYalin, K.
dc.contributor.authorLyan, E.
dc.contributor.authorSu, W.
dc.contributor.authorPapiashvili, G.
dc.contributor.authorBotros, M.S.N.
dc.contributor.authorGasperetti, A.
dc.contributor.authorProietti, R.
dc.contributor.authorWissner, E.
dc.contributor.authorScherr, D.
dc.contributor.authorKamioka, M.
dc.contributor.authorMakimoto, H.
dc.contributor.authorUrushida, T.
dc.contributor.authorAksu, T.
dc.contributor.authorChun, J.K.R.
dc.contributor.authorAytemir, K.
dc.contributor.authorJȩdrzejczyk-Patej, E.
dc.contributor.authorKuck, K.-H.
dc.contributor.authorDahme, T.
dc.contributor.authorSteven, D.
dc.contributor.authorSommer, P.
dc.contributor.authorTilz, R.R.
dc.date.accessioned2024-08-09T00:15:11Z
dc.date.available2024-08-09T00:15:11Z
dc.date.issued2022-11-23
dc.identifier.citationChristian-H Heeger, Sorin Ștefan Popescu, Christian Sohns, Alexander Pott, Andreas Metzner, Osamu Inaba, Florian Straube, Malte Kuniss, Arash Aryana, Shinsuke Miyazaki, Serkan Cay, Joachim R Ehrlich, Ibrahim El-Battrawy, Martin Martinek, Ardan M Saguner, Verena Tscholl, Kivanc Yalin, Evgeny Lyan, Wilber Su, Giorgi Papiashvili, Maichel Sobhy Naguib Botros, Alessio Gasperetti, Riccardo Proietti, Erik Wissner, Daniel Scherr, Masashi Kamioka, Hisaki Makimoto, Tsuyoshi Urushida, Tolga Aksu, Julian K R Chun, Kudret Aytemir, Ewa Jędrzejczyk-Patej, Karl-Heinz Kuck, Tillman Dahme, Daniel Steven, Philipp Sommer, Roland Richard Tilz, Impact of cryoballoon application abortion due to phrenic nerve injury on reconnection rates: a YETI subgroup analysis, EP Europace, Volume 25, Issue 2, February 2023, Pages 374–381, https://doi.org/10.1093/europace/euac212
dc.identifier.issn1099-5129
dc.identifier.pmid36414239
dc.identifier.doi10.1093/europace/euac212
dc.identifier.urihttp://hdl.handle.net/10150/674010
dc.description.abstractAims: Cryoballoon (CB)-based pulmonary vein isolation (PVI) is an effective treatment for atrial fibrillation (AF). The most frequent complication during CB-based PVI is right-sided phrenic nerve injury (PNI) which is leading to premature abortion of the freeze cycle. Here, we analysed reconnection rates after CB-based PVI and PNI in a large-scale population during repeat procedures. Methods and results: In the YETI registry, a total of 17 356 patients underwent CB-based PVI in 33 centres, and 731 (4.2%) patients experienced PNI. A total of 111/731 (15.2%) patients received a repeat procedure for treatment of recurrent AF. In 94/111 (84.7%) patients data on repeat procedures were available. A total of 89/94 (94.7%) index pulmonary veins (PVs) have been isolated during the initial PVI. During repeat procedures, 22 (24.7%) of initially isolated index PVs showed reconnection. The use of a double stop technique did non influence the PV reconnection rate (P = 0.464). The time to PNI was 140.5 ± 45.1 s in patients with persistent PVI and 133.5 ± 53.8 s in patients with reconnection (P = 0.559). No differences were noted between the two populations in terms of CB temperature at the time of PNI (P = 0.362). The only parameter associated with isolation durability was CB temperature after 30 s of freezing. The PV reconnection did not influence the time to AF recurrence. Conclusion: In patients with cryoballon application abortion due to PNI, a high rate of persistent PVI rate was found at repeat procedures. Our data may help to identify the optimal dosing protocol in CB-based PVI procedures. Clinical Trial Registration: https://clinicaltrials.gov/ct2/show/NCT03645577?term=YETI&cntry=DE&draw=2&rank=1 ClinicalTrials.gov Identifier: NCT03645577. © 2022 The Author(s). Published by Oxford University Press on behalf of the European Society of Cardiology.
dc.language.isoen
dc.publisherOxford University Press
dc.rights© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/).
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.subjectAtrial fibrillation
dc.subjectCatheter ablation
dc.subjectCryoballoon
dc.subjectPhrenic nerve injury
dc.titleImpact of cryoballoon application abortion due to phrenic nerve injury on reconnection rates: a YETI subgroup analysis
dc.typeArticle
dc.typetext
dc.contributor.departmentUniversity of Arizona
dc.identifier.journalEuropace
dc.description.noteOpen access article
dc.description.collectioninformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.
dc.eprint.versionFinal Published Version
dc.source.journaltitleEuropace
refterms.dateFOA2024-08-09T00:15:11Z


Files in this item

Thumbnail
Name:
euac212.pdf
Size:
340.0Kb
Format:
PDF
Description:
Final Published Version

This item appears in the following Collection(s)

Show simple item record

© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/).
Except where otherwise noted, this item's license is described as © The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/).